Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence

Andrew Vickers,Sigrid V Carlsson,Matthew Cooperberg

doi:10.1016/j.eururo.2020.04.016

Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence

Andrew Vickers, Sigrid V Carlsson + Show 1 more

Open Access

https://doi.org/10.1016/j.eururo.2020.04.016

Copy DOI

Journal: European urology	Publication Date: May 7, 2020
Citations: 53

Affiliation: Memorial Sloan Kettering Cancer Center, University of Gothenburg, University of California, San Francisco

#Resonance Imaging For Early Detection #Early Detection Of Prostate Cancer + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Guidelines now recommend multiparametric magnetic resonance imaging before prostate biopsy in the work-up for patients with elevated prostate specific-antigen. However, use of magnetic resonance imaging for early detection of prostate cancer is not justified by the clinical trial evidence.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

More From: European urology

Paper Title

Journal

Date

Author

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.